Species Information: Caenorhabditis elegans

Name Caenorhabditis elegans
NCBI Taxonomy ID 6239

Caenorhabditis elegans strains available at the CGC

Strain Genotype Description
BC4846 dpy-17(e164) let-722(s2816) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4847 dpy-17(e164) let-832(s2817) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4848 dpy-17(e164) let-816(s2818) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4849 dpy-17(e164) let-767(s2819) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Animals with the duplication are Unc. See also WBPaper00002901.
BC4850 dpy-17(e164) let-826(s2820) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4851 dpy-17(e164) let-839(s2821) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4852 dpy-17(e164) let-796(s2822) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4853 dpy-17(e164) let-817(s2823) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4854 dpy-17(e164) let-797(s2824) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4855 dpy-17(e164) let-793(s2825) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4856 dpy-17(e164) let-829(s2826) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4857 dpy-17(e164) let-827(s2827) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4858 dpy-17(e164) let-830(s2828) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4859 dpy-17(e164) let-814(s2829) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4860 dpy-17(e164) let-743(s2830) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4862 let-736(s2832) dpy-17(e164) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4863 dpy-17(e164) cyk-1(s2833) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs. cyk-1 was previously known as let-794 (in Stewart et al 1998).
BC4864 dpy-17(e164) let-837(s2834) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4865 dpy-17(e164) let-818(s2835) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4866 dpy-17(e164) let-810(s2836) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4867 let-734(s2837) dpy-17(e164) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs. pka let-833(s2837).
BC4868 let-791(s2838) dpy-17(e164) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4869 dpy-17(e164) let-838(s2839) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4870 dpy-17(e164) let-775(s2840) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4873 let-819(s2843) dpy-17(e164) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4874 dpy-17(e164) let-809(s2844) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4875 let-820(s2845) dpy-17(e164) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4876 let-840(s2846) dpy-17(e164) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4878 let-822(s2848) dpy-17(e164) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4879 dpy-17(e164) let-795(s2849) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4880 dpy-17(e164) let-798(s2850) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs. DpyUncs die as embryos.
BC4881 dpy-17(e164) let-842(s2851) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4882 dpy-17(e164) let-799(s2852) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4883 let-831(s2853) dpy-17(e164) ncl-1(e1865) unc-32(e189) III; sDp3 (III;f). Maintain by picking Uncs.
BC4885 sEx124. sEx124 [K07E12 (III) + pCes1943[rol-6(su1006)]]. segrgnt 2. 20 ng/ul K07E12 + 80 ng/ul pCes1943[rol-6(su1006dm)] injected into hermaphrodite from BC842 (N2 male strain). pCes1943 carries rol-6(su1006) [an EcoRI insert from pRF4] and a kanamycin cassette. Select Rollers to maintain. Presence of cosmid confirmed by PCR. This transgenic strains were constructed in collaboration with the C. elegans Genome Sequencing Consortium Labs in St. Louis, MO and Hinxton, Cambridge, UK. Funding for the creation of this transgenic strain was provided by a grant to Ann Rose and David Baillie from the Canadian Genome Analysis and Technology Program (CGAT), and from a grant from NSERC (Canada) to David Baillie. If you use this strain in work which you publish, please acknowledge these grants.
BC4890 sEx126. sEx126 [K03F8 (III) + pCes1943[rol-6(su1006)]]. segrgnt 2. 20 ng/ul K03F8 + 80 ng/ul pCes1943[rol-6(su1006dm)] injected into hermaphrodite from BC842 (N2 male strain). pCes1943 carries rol-6(su1006) [an EcoRI insert from pRF4] and a kanamycin cassette. Select Rollers to maintain. Presence of cosmid confirmed by PCR. This transgenic strains were constructed in collaboration with the C. elegans Genome Sequencing Consortium Labs in St. Louis, MO and Hinxton, Cambridge, UK. Funding for the creation of this transgenic strain was provided by a grant to Ann Rose and David Baillie from the Canadian Genome Analysis and Technology Program (CGAT), and from a grant from NSERC (Canada) to David Baillie. If you use this strain in work which you publish, please acknowledge these grants.
BC4892 sEx128. sEx128 [M01G4 (III) + pCes1943[rol-6(su1006)]]. 20 ng/ul M01G4 + 80 ng/ul pCes1943[rol-6(su1006dm)] injected into hermaphrodite from BC842 (N2 male strain). pCes1943 carries rol-6(su1006) [an EcoRI insert from pRF4] and a kanamycin cassette. Select Rollers to maintain. Presence of cosmid confirmed by PCR. This transgenic strains were constructed in collaboration with the C. elegans Genome Sequencing Consortium Labs in St. Louis, MO and Hinxton, Cambridge, UK. Funding for the creation of this transgenic strain was provided by a grant to Ann Rose and David Baillie from the Canadian Genome Analysis and Technology Program (CGAT), and from a grant from NSERC (Canada) to David Baillie. If you use this strain in work which you publish, please acknowledge these grants.
BC4909 sEx134. sEx134 [F42A10 (III) + pCes1943[rol-6(su1006)]]. segrgnt 2. 20 ng/ul F42A10 + 80 ng/ul pCes1943[rol-6(su1006dm)] injected into hermaphrodite from BC842 (N2 male strain). pCes1943 carries rol-6(su1006) [an EcoRI insert from pRF4] and a kanamycin cassette. Select Rollers to maintain. Presence of cosmid confirmed by PCR. This transgenic strains were constructed in collaboration with the C. elegans Genome Sequencing Consortium Labs in St. Louis, MO and Hinxton, Cambridge, UK. Funding for the creation of this transgenic strain was provided by a grant to Ann Rose and David Baillie from the Canadian Genome Analysis and Technology Program (CGAT), and from a grant from NSERC (Canada) to David Baillie. If you use this strain in work which you publish, please acknowledge these grants.
BC4913 sEx136. sEx136 [F28F5 (III) + pCes1943[rol-6(su1006)]]. 10ng/ul mini-prepped F28F5 + 90 ng/ul pCes1943[rol-6(su1006dm)] injected into hermaphrodite from BC842 (N2 male strain). pCes1943 carries rol-6(su1006) [an EcoRI insert from pRF4] and a kanamycin cassette. Select Rollers to maintain. Presence of cosmid confirmed by PCR. This transgenic strains were constructed in collaboration with the C. elegans Genome Sequencing Consortium Labs in St. Louis, MO and Hinxton, Cambridge, UK. Funding for the creation of this transgenic strain was provided by a grant to Ann Rose and David Baillie from the Canadian Genome Analysis and Technology Program (CGAT), and from a grant from NSERC (Canada) to David Baillie. If you use this strain in work which you publish, please acknowledge these grants.
BC4914 sEx137. sEx137 [C05D11 (III) + pCes1943[rol-6(su1006)]]. segrgnt 3. 20 ng/ul C05D11 + 80 ng/ul pCes1943[rol-6(su1006dm)] injected into hermaphrodite from BC842 (N2 male strain). pCes1943 carries rol-6(su1006) [an EcoRI insert from pRF4] and a kanamycin cassette. Select Rollers to maintain. Presence of cosmid confirmed by PCR. This transgenic strains were constructed in collaboration with the C. elegans Genome Sequencing Consortium Labs in St. Louis, MO and Hinxton, Cambridge, UK. Funding for the creation of this transgenic strain was provided by a grant to Ann Rose and David Baillie from the Canadian Genome Analysis and Technology Program (CGAT), and from a grant from NSERC (Canada) to David Baillie. If you use this strain in work which you publish, please acknowledge these grants.
BC4915 sEx138. sEx138 [K06G1 (I) + PCes1943[rol-6(su1006)]]. segrgnt. 2. 5ng/ul mini-prepped K06G1 + 90 ng/ul pCes1943[rol-6(su1006dm)] injected into hermaphrodite from BC842 (N2 male strain). pCes1943 carries rol-6(su1006) [an EcoRI insert from pRF4] and a kanamycin cassette. Select Rollers to maintain. Presence of cosmid confirmed by PCR. This transgenic strains were constructed in collaboration with the C. elegans Genome Sequencing Consortium Labs in St. Louis, MO and Hinxton, Cambridge, UK. Funding for the creation of this transgenic strain was provided by a grant to Ann Rose and David Baillie from the Canadian Genome Analysis and Technology Program (CGAT), and from a grant from NSERC (Canada) to David Baillie. If you use this strain in work which you publish, please acknowledge these grants.
BC4916 sEx139. sEx139 [F44E2 (III) + pCes1943[rol-6(su1006)]]. 20 ng/ul F44E2 + 80 ng/ul pCes1943[rol-6(su1006dm)] injected into hermaphrodite from BC842 (N2 male strain). pCes1943 carries rol-6(su1006) [an EcoRI insert from pRF4] and a kanamycin cassette. Select Rollers to maintain. Presence of cosmid confirmed by PCR. This transgenic strains were constructed in collaboration with the C. elegans Genome Sequencing Consortium Labs in St. Louis, MO and Hinxton, Cambridge, UK. Funding for the creation of this transgenic strain was provided by a grant to Ann Rose and David Baillie from the Canadian Genome Analysis and Technology Program (CGAT), and from a grant from NSERC (Canada) to David Baillie. If you use this strain in work which you publish, please acknowledge these grants.
BC4923 egl-38(sy294) IV; him-5(e1490) V.
BC4925 sEx142. sEx142 [T12A2 (III) + pCes1943[rol-6(su1006)]]. segrgnt. 2. 10 ng/ul T12A2 + 90 ng/ul pCes1943[rol-6(su1006dm)] injected into hermaphrodite from BC842 (N2 male strain). pCes1943 carries rol-6(su1006) [an EcoRI insert from pRF4] and a kanamycin cassette. Select Rollers to maintain. Presence of cosmid confirmed by PCR. This transgenic strains were constructed in collaboration with the C. elegans Genome Sequencing Consortium Labs in St. Louis, MO and Hinxton, Cambridge, UK. Funding for the creation of this transgenic strain was provided by a grant to Ann Rose and David Baillie from the Canadian Genome Analysis and Technology Program (CGAT), and from a grant from NSERC (Canada) to David Baillie. If you use this strain in work which you publish, please acknowledge these grants.
BC4926 sEx143. sEx143 [T12A2 (III) + pCes1943[rol-6(su1006)]]. segrgnt 3. 10 ng/ul T12A2 + 90 ng/ul pCes1943[rol-6(su1006dm)] injected into hermaphrodite from BC842 (N2 male strain). pCes1943 carries rol-6(su1006) [an EcoRI insert from pRF4] and a kanamycin cassette. Select Rollers to maintain. Presence of cosmid confirmed by PCR. This transgenic strains were constructed in collaboration with the C. elegans Genome Sequencing Consortium Labs in St. Louis, MO and Hinxton, Cambridge, UK. Funding for the creation of this transgenic strain was provided by a grant to Ann Rose and David Baillie from the Canadian Genome Analysis and Technology Program (CGAT), and from a grant from NSERC (Canada) to David Baillie. If you use this strain in work which you publish, please acknowledge these grants.
BC4927 sEx144. sEx144 [C23G10 (III) + pCes1943[rol-6(su1006)]]. segrgnt 1. 20 ng/ul C23G10 + 80 ng/ul pCes1943[rol-6(su1006dm)] injected into hermaphrodite from BC842 (N2 male strain). pCes1943 carries rol-6(su1006) [an EcoRI insert from pRF4] and a kanamycin cassette. Select Rollers to maintain. Presence of cosmid confirmed by PCR. This transgenic strains were constructed in collaboration with the C. elegans Genome Sequencing Consortium Labs in St. Louis, MO and Hinxton, Cambridge, UK. Funding for the creation of this transgenic strain was provided by a grant to Ann Rose and David Baillie from the Canadian Genome Analysis and Technology Program (CGAT), and from a grant from NSERC (Canada) to David Baillie. If you use this strain in work which you publish, please acknowledge these grants.
BC4929 sEx146. sEx146 [C05D10 (III) + pCes1943[rol-6(su1006)]]. segrgnt. 1. 20 ng/ul C05D10 + 80 ng/ul pCes1943[rol-6(su1006dm)] injected into hermaphrodite from BC842 (N2 male strain). pCes1943 carries rol-6(su1006) [an EcoRI insert from pRF4] and a kanamycin cassette. Select Rollers to maintain. Presence of cosmid confirmed by PCR. This transgenic strains were constructed in collaboration with the C. elegans Genome Sequencing Consortium Labs in St. Louis, MO and Hinxton, Cambridge, UK. Funding for the creation of this transgenic strain was provided by a grant to Ann Rose and David Baillie from the Canadian Genome Analysis and Technology Program (CGAT), and from a grant from NSERC (Canada) to David Baillie. If you use this strain in work which you publish, please acknowledge these grants.
BC4931 sEx148. sEx148 [C05D11 (III) + pCes1943[rol-6(su1006)]]. segrgnt 5. 20 ng/ul C05D11 + 80 ng/ul pCes1943[rol-6(su1006dm)] injected into hermaphrodite from BC842 (N2 male strain). pCes1943 carries rol-6(su1006) [an EcoRI insert from pRF4] and a kanamycin cassette. Select Rollers to maintain. Presence of cosmid confirmed by PCR. This transgenic strains were constructed in collaboration with the C. elegans Genome Sequencing Consortium Labs in St. Louis, MO and Hinxton, Cambridge, UK. Funding for the creation of this transgenic strain was provided by a grant to Ann Rose and David Baillie from the Canadian Genome Analysis and Technology Program (CGAT), and from a grant from NSERC (Canada) to David Baillie. If you use this strain in work which you publish, please acknowledge these grants.
BC4932 sEx149. sEx149 [F56D2 (III) + pCes1943[rol-6(su1006)]]. 20 ng/ul FF56D2 + 80 ng/ul pCes1943[rol-6(su1006dm)] injected into hermaphrodite from BC842 (N2 male strain). pCes1943 carries rol-6(su1006) [an EcoRI insert from pRF4] and a kanamycin cassette. Select Rollers to maintain. Presence of cosmid confirmed by PCR. This transgenic strains were constructed in collaboration with the C. elegans Genome Sequencing Consortium Labs in St. Louis, MO and Hinxton, Cambridge, UK. Funding for the creation of this transgenic strain was provided by a grant to Ann Rose and David Baillie from the Canadian Genome Analysis and Technology Program (CGAT), and from a grant from NSERC (Canada) to David Baillie. If you use this strain in work which you publish, please acknowledge these grants.
BC4936 sEx152. sEx152 [C05D2 (III) + pCes1943[rol-6(su1006)]]. 20 ng/ul C05D2 + 80 ng/ul pCes1943[rol-6(su1006dm)] injected into hermaphrodite from BC842 (N2 male strain). pCes1943 carries rol-6(su1006) [an EcoRI insert from pRF4] and a kanamycin cassette. Select Rollers to maintain. Presence of cosmid confirmed by PCR. This transgenic strains were constructed in collaboration with the C. elegans Genome Sequencing Consortium Labs in St. Louis, MO and Hinxton, Cambridge, UK. Funding for the creation of this transgenic strain was provided by a grant to Ann Rose and David Baillie from the Canadian Genome Analysis and Technology Program (CGAT), and from a grant from NSERC (Canada) to David Baillie. If you use this strain in work which you publish, please acknowledge these grants.